Skip to main content
. Author manuscript; available in PMC: 2009 Dec 8.
Published in final edited form as: Mutat Res. 2006 Nov 20;627(1):92–105. doi: 10.1016/j.mrgentox.2006.10.006

Table 4.

Mouse bone marrow micronucleus test of Alimta®

Agent Dose (mg/kg) PCE/NCE ratio (±S.D.) MNPCE/1000 PCE (±S.D.)
Vehicle control 1.2 (0.3) 1.2 (1.1)
Alimta® 393.5 1.1 (0.4) 5.0 (2.4)
787.1 0.7 (0.2) 4.8 (2.2)
1574.1 0.8 (0.1) 4.3a (2.2)
Cyclophosphamide (positive control) 25.0 1.0 (0.2) 16.4 (1.5)

Two equal i.v. doses were given 24 h apart to ICR mice, with harvest 24 h after the second treatment. Male mouse data shown (five per group); similar results obtained in female mice. PCE: polychromatic erythrocyte; NCE: normochromatic erythrocyte; MNPCE: micronucleated PCE.

a

p = 0.02, treated groups were significantly increased relative to the vehicle control as determined by a two-tailed trend test.